Article
Multi-target RNA interference: A disruptive next-generation strategy for precision treatment of rheumatoid arthritis
19 May 2025
Abstract excerpt
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic joint inflammation. Existing therapeutic regimens, including disease-modifying anti-rheumatic drugs (DMARDs) and biologics, exhibit incomplete efficacy and pronounced limitations. RNA interference (RNAi) utilizing small interfering RNA (siRNA) facilitates the precise silencing of key pathological drivers in rheumatoid arthritis (RA), such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
